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Abstract 
Some mucin genes have been detected dur-
ing human embryonic and fetal organ develop-
ment; however, little is known about mucin
expression in epidermal development, neither
in humans nor in other species. The present
research was developed to explore Muc5ac
skin expression during pre- and post-natal rat
development. Immunohistochemistry (IHC),
Western blotting (WB) and RT-PCR were
employed. By IHC, Muc5ac protein was found
early in embryonic epidermis from day 13 of
gestation until seven days after birth when the
surface epidermis became negative and the
reaction was restricted to secreting sebum
cells. In coincidence with IHC findings, WB
analysis showed a band at approximately
200KDa at the same periods of development.
Results were also confirmed by RT-PCR.
Muc5ac expression in rat embryonic epider-
mis suggests that Muc5ac may play a protec-
tive role in embryonic skin previous to birth
which may be replaced by pile covering. To our
knowledge, this is the first report that con-
firmed Muc5ac expression during skin devel-
opment. 
Introduction
The skin is the largest organ in the mammal
body and serves as the first line of defense
against external agents. During epidermal
development, a single layer of epithelial cells is
converted into multiple layers of terminally dif-
ferentiating cells that continuously migrate
outward and are shed from the body surface.
This tissue architecture is precisely main-
tained and renewed throughout life.1
Mucins are large, highly O-glycosylated gly-
coproteins implicated in the protection of sur-
face epithelia.2,3 The Muc5ac is a large soluble
mucin gel-forming which is part of the protec-
tive layer of mucus covering gastrointestinal
and airways epithelia.2 It is common knowl-
edge that normal skin exhibits a rather
restricted expression of mucins, and it has
been demonstrated that epithelial cells of the
normal epidermis do not express sialomucins
while Muc5ac expression in cancer epidermal
cells is well documented.4,5 On the other hand,
little is known about mucin expression in epi-
dermal development, neither in humans nor in
other species. However, some mucin genes
have been detected during human embryonic
and fetal organ development according to dif-
ferential expression patterns in comparison
with adult tissues.3,6
The present research was developed to
explore Muc5ac skin expression during pre-
and post-natal rat development.
Materials and MethodsAnimals and samples
A total of 160 animals were included in this
study: 64 rat embryos and fetuses were collect-
ed at 13-20 days of gestation (stages D13-D20)
from pregnant females (WKAH/Hok), neonates
of 2, 3, 4, 5, 6, 7, 8, 9, 10 and 15 post-natally
days (2PD - 15PD) and adults of 10-12 weeks;
8 individuals from each stage of development
were included. Eight skin samples belonging to
each development stage were examined and
scored.
This investigation was carried out in accor-
dance with the Guide for the Care and Use of
Laboratory Animals published by the Institute
for Laboratory Animal Research (Washington
DC, USA, 2011).Samples of embryos and fetusesprocessing
Embryos and fetuses were obtained by
laparotomy and hysterectomy of the pregnant
females. The number of breeding in each ges-
tation, which were processed and studied,
ranged from 4 to 12.
After the extirpation of the embryonic sac,
the whole embryos and fetuses were separated
according to further programmed analysis.7
For immunohistochemistry (IHC), animals
were washed with 0.01M saline phosphate
buffer pH 7.4 (PBS) and fixed in 10% (v/v)
formaldehyde solution for 3 h. To prepare the
homogenates, the skin specimens were placed
in cold PBS, pH 7.4 and immediately trans-
ferred to lysis buffer containing 0.01M TRIS-
HCl, pH 7.4 and 0.01M phenylmethylsulfonyl-
fluoride (PMSF; Sigma-Aldrich, St. Louis, MO,
USA), in a ratio of 4 mL/g for subsequent
homogenization. To analyze mRNA expression,
skin samples were placed in RNAlater®
(Invitrogen, Carlsbad, CA, USA).
Samples of neonates and adultsprocessing
Neonates and adults were dissected and the
skin samples were separated. Each sample was
sectioned to cover different programmed stud-
ies: a piece was fixed in 10% (v/v) formalde-
hyde solution for immunohistochemical analy-
sis, another piece was included in lysis buffer
for subsequent homogenization, and finally, a
third piece was placed in RNAlater®
(Invitrogen) for subsequent analysis of mRNA
expression.Antibodies
An anti-human MUC5AC mouse monoclonal
antibody (MAb) was used (45M1, IgG1, culture
supernatant),8 which was previously tested in
adult rat tissue. The corresponding epitopes
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are encoded by the Muc5ac gene. The 45M1
epitope has been located in the cys9 domain of
the C-terminal region of the MUC5AC apo-
mucin.9  Two antibodies were used to recognize
different types of epidermal cells, 3H2061
(Santa Cruz Biotechnologies, Santa Cruz, CA,
USA), a mouse monoclonal anti-human cytok-
eratin 5/6/18 and EP1024Y (Abcam,
Cambridge, UK), rabbit monoclonal antibody
raised against human MUC1.Immunohistochemical analysis 
Immunohistochemistry was performed
according to standard procedures as reported
in previous studies.10 Briefly, immunodetec-
tion was performed with the Dako Cytomation
LSAB+System-HRP (Dako, Glostrup,
Denmark). Finally, sections were counter-
stained with hematoxylin (Sigma), dehydrated
and coverslipped with mounting media.
Samples were evaluated under light micro-
scope and the percentage of cells positively
stained in one sample was quantified: 0-5%=0;
5-30%=1; 31-60%=2 and 61-100%=3. The pat-
terns of reaction were: L, linear membrane; C,
cytoplasmic; and M, mixed, linear and cytoplas-
mic. Staining intensity was scored in a semi
quantitative manner and was graded as: -, neg-
ative; +, low; ++, moderate; and +++, strong. Preparation of homogenates
Homogenates were obtained from embryon-
ic, fetal, neonatal and adult rat skin specimens
as previously reported.11 Protein concentration
was measured by Bradford assay (Bio-Rad
Laboratories, Hercules, CA, USA) to achieve
the same protein amount in each assay and
samples were stored at -70°C.SDS-PAGE and Western blot 
Homogenates that contained 50 µg total pro-
tein were diluted in 25% SDS and 10% glicerol
and heated at 90°C for 5 min and separated on
a 4-6% mini gels and blotted onto nitrocellu-
lose transfer membranes (Schleicher and
Schuell). Membranes were incubated with
45M1 MAb (1 μg/mL) at 4°C overnight followed
by horseradish peroxidase (HRP)-conjugated
goat anti-mouse IgG antibody (Dako) (1:1000);
protein bands were detected by autoradiogra-
phy. The corresponding negative controls were
included in the absence of primary antibody.RT-PCR analysis of Muc5ac mRNA
Total RNA was isolated from embryonic,
fetal and adult skin samples using TRIZOL
Reagent® (Invitrogen) following the manufac-
turer’s protocols. RNA integrity was assessed
by electrophoresis in 1.5% agarose formalde-
hyde denaturing minigel. Before RT-PCR, the
RNA samples were treated with DNAse I (1
U/L) (Fermentas Life Sciences, Burlington,
Ont., Canada). The cDNAs were synthesized
using SuperScriptTM First-strand Synthesis
System (Invitrogen, USA) and measured using
a NanoDrop Spectrophotometer® 2000. For
mRNA expression analysis, 500 ng of total
cDNA for each sample was employed. RNA 18S
was used as reference.
The following primers were used: Muc5ac
Forward, 5 -AACTCTGCCCACCACAAGC-3,
Muc5ac Reverse, 5 - ATTGGACTGATTGGATA-
GATGGCA-3 , designed against the rat mRNA
Muc5ac sequence XM_001063331.5;12 RNA18s
Forward, 5 -GTAACCCGTTGAACCCCATT -3 ,
RNA18s Reverse, 5 -CCATCCAATCGGTAG-
TAGCG-3 .13 Muc5ac and RNA18s product sizes
are 149 and 151 bp, respectively. Thermal pro-
file was programmed as follows: Muc5ac, an
initial denaturation step of 3 min at 95°C fol-
lowed by 45 cycles of 20 s at 94°C, 20 s at 65°C
and 20 s at 72°C and a final extension at 72°C
for 2 min; RNA18s, at an initial denaturing
step of 2 min at 94°C followed by 35 cycles of
40 s at 94°C, 50 s at 50°C and 30 s at 72°C and
a final extension at 72°C by 5 min.  Detection
of the amplified fragments was made by elec-
trophoresis onto 8% polyacrylamide gels and
silver staining. These experiments were per-
formed in triplicate. The corresponding nega-
tive controls were included using H20 instead
of cDNA sample.
Results
By IHC, Muc5ac protein was found early in
embryonic epidermis, at day 13 of gestation
(D13), with a moderate intensity and a pre-
dominantly cytoplasmic pattern (Table 1)
(Figure 1A); from D16, the intensity of the
reaction increased (Figure 1 B-F). Muc5ac
expression was further analyzed in rat neona-
tal skin samples at different days of develop-
ment from 2 to 15 days after birth (post-natal
development, PD); in samples obtained
between 2 and 6PD, a high intensity was
detected at different layers of the epidermis. In
addition, secretory cells of the sebaceous
glands associated with hair follicles showed
Muc5ac expression (Figure 2A). At 7PD, the
surface epidermis became negative and the
reaction was restricted to secreting sebum
cells (Figure 2B) which showed a strong cyto-
plasmic reaction; these results are in accor-
dance with those obtained on adult rat samples
(Figure 2 C,D). Expression of cytokeratin 5/6
(ck5/6) and Muc1 was also analyzed in rat skin
samples of embryos, neonates and adults at
different days of development. Both Ck5/6 and
Muc1 were negative in embryonic epidermis
(Figure 3 A-C; Figure 4A). However, both anti-
gens were restricted to secreting sebum cells
and in some cases to basal keratinocytes in
neonatal and adult skin samples (Figure 3D;
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Figure 1. Immunohistochemical staining of Muc5ac in rat embryonic epidermis employ-
ing anti-MUC5AC MAb, 45M1. A) An embryonic epidermis at 13 days of gestation
shows a moderate cytoplasmic reaction. B, C) Epidermis at 16 days of gestation depicts
an increased staining. D) Epidermis at 18 days of gestation. E) Epidermis at 20 days of
development. F) Magnification of the box in panel E. Black arrows indicate the positive
reaction.
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Figure 4 B-D). The reaction was low in
neonates and moderate in adults. 
To further characterize rat skin Muc5ac,
SDS-PAGE and WB were employed. In accor-
dance to IHC results, a variation of expression
was found. Embryonic samples showed a band
at approximately 200 kDa between 17 and 20
days before birth (Figure 5A) while neonatal
skin samples showed a strong intensity of
reaction at early days post-birth and a lower
intensity at 10PD (Figure 5B). In order to ana-
lyze mRNA Muc5ac expression in rat skin,
cDNA samples were obtained at different ges-
tational ages and RT-PCR analysis was per-
formed. All cases showed an amplified of ~149
bp (Figure 6).
Discussion
In this study, we analyzed Muc5ac expres-
sion in rat skin samples employing a mono-
clonal antibody against the C-terminal region
of the human MUC5AC apomucin. Human
MUC5AC was first cloned from tracheo-
bronchial and stomach cDNA libraries while
rat Muc5ac gene was cloned by Inatomi et al.14
from conjunctival goblet cells and stomach
mucosal epithelia. MUC5AC expression in epi-
dermal cells has been associated to certain
skin conditions such as extra-mammary
Pagets disease, a rare epidermal carcino-
ma.5,15 In consequence, the interest of
MUC5AC has been mainly focused on their
functions in carcinogenesis and the possibility
of its employment as a tumor marker. In con-
trast, its expression in normal skin and fur-
thermore its role in skin development remains
unexplored. 
In embryonic epidermis, we demonstrated
by IHC rat Muc5ac expression from D13. The
reaction was restricted to epidermal cells cov-
ering the embryo's body. At this stage, the rat
skin consists in 3-5 layers of undifferentiated
cells. From D16 until birth, a very rapid epider-
mal proliferation occurs and the undifferenti-
ated epithelium becomes a cornified multilay-
ered epithelium, which is in coincidence with
the higher intensity of Muc5ac expression in
embryonic epidermis. The MUC5AC/Muc5ac
cytoplasmic pattern found in our present
analysis is in coincidence with our previous
report,1 in which the MAb 45M1 was used to
perform an exhaustively analysis in order to
identify and localize the Muc5ac in different
tissues of diverse mammalian species. A
strong cytoplasmic reaction was found in adult
surface gastric epithelium of rat, cat, rabbit,
pig, and cow specimens as well as goblet cells
from upper and lower mammalian respiratory
tract. Other authors also found a cytoplasmic
pattern in human specimens; Biemer-
Hüttmann et al.16 found in human normal
colon specimens Muc5ac cytoplasmic staining.
It is possible that the cytoplasmic reaction that
we have found both in embryonic skin cells as
well as in neonate and adult sebum secreting
cells may be due to the high Muc5ac synthesis
which would be visualized at the whole cyto-
plasm. Following the model proposed by
Sheehan et al.17 for HT29 cell line in culture,
the biosynthetic Muc5ac process would devel-
op in the endoplasmic reticulum. There, the
mucin forms disulfide-linked dimera via their
C termini, then, GalNac addition occurs in the
end endoplasmic reticulum/Golgi; thereafter,
the glycan would be elaborated with the fully
glycosylation of the dimers, which multimerize
via disulfide linkage between their N-termini. 
On the other hand, we found an intense
reaction in several layers of the epidermis of
the neonatal skin between 2PD and 6PD, and
surprisingly, also sebaceous glands were posi-
tive. These structures are originating as
prominences associated to developing hair fol-
licles and appear during the first week of life in
rats and mice.18 At 7PD, the epidermis became
negative and the reaction was restricted to
sebaceous cells, which is similar to adult
expression. The absence of rat Muc5ac expres-
sion in epidermis was coincident with hair
appearance. In consequence, and taking into
account that MUC5AC role is mainly protec-
tive2, it may be suggested that at prenatal
                             Brief Report
Figure 2. Expression of Muc5ac determinates using immunohistochemistry in rat skin of
neonates and adults. A) Epidermis at 4 post-natal days; the reaction is observed at the epi-
dermis, hair follicle and sebaceous gland. B) Epidermis at 7 days after birth, in which the
reaction is restricted to the secreting sebum cells. C, D) Adult skin showing the positive
reaction in the sebaceous gland and the negative epidermis. Black arrows indicate the
positive epidermis and white arrows indicate the sebaceous gland showing positive
expression.
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stages, skin rat Muc5ac could behave as a pro-
tection against possible damage agents, such
as amniotic fluid. Probably, after birth, this
protective function would be assumed by hair
coating. Zhang et al.19 have studied another
mucin, MUC4, and they found its significant
staining on the stratified epithelium in the
early human embryo and also their absence in
adult skin. They suggested that MUC4 would
play a protective role during a specific stage of
development which is not later required since
epithelial differentiation occurs. At present, in
the case of MUC5AC/Muc5ac, there is no infor-
mation about its expression during embryolog-
ic development; furthermore, Muc5ac expres-
sion in normal adult skin is scarce and most
authors consider that MUC5AC is not
expressed in normal adult epidermis. However,
the protective role of the Muc5ac mucin in
other tissues such as gastric mucosa and air-
ways has been postulated by several
authors.2,20,21
In order to identify sebum cells at different
stages of development, in embryonic, neonate
and adult specimens, cytokeratins 5/6 and
Muc1 expression was analyzed. These anti-
gens constitute good markers of secreting
sebum cells, and it is known that cytokeratins
5/6 are expressed on squamous epithelium
                                                                                                           Brief Report
Table 1. Immunohistochemical results of Muc5ac expression in embryonic, fetal, neonatal, and adult rat skin.
                                                                   Positive cases/                        Specific localization                               Intensity of reaction
                                                                      total cases              Epidermis              Sebaceous glands                                 
       
       
Stages of development embryos and fetuses
(days of gestation)
         D13                                                                                    6/8                                     +                                                -                                                             ++
         D14                                                                                    7/8                                     +                                                -                                                             ++
         D15                                                                                    7/8                                     +                                                -                                                             ++
         D16                                                                                    5/8                                     +                                                -                                                             ++
         D17                                                                                    6/8                                     +                                                -                                                             ++
         D18                                                                                    7/8                                     +                                                -                                                             +++
         D19                                                                                    6/8                                     +                                                -                                                             +++
         D20                                                                                    5/8                                     +                                                -                                                             +++
Neonates (post-natal days)                                                                                                                                                
         2PD                                                                                    7/8                                     +                                                +                                                            +++
         3PD                                                                                    6/8                                     +                                                +                                                            +++
         4PD                                                                                    5/8                                     +                                                +                                                            +++
         5PD                                                                                    6/8                                     +                                                +                                                            +++
         6PD                                                                                    6/8                                     +                                                +                                                            +++
         7PD                                                                                    5/8                                      -                                                 +                                                            +++
         8-15PD                                                                            28/32                                    -                                                 +                                                            +++
Adults                                                                                                                                                                                       
         8-12 weeks                                                                    14/16                                    -                                                 +                                                            +++
-, negative; +, low; ++, moderate; +++, strong. 
Figure 3. Immunohistochemical findings employing anti-ck 5/6/18 Mab, EP1024Y. A)
Epidermis at 16 days of gestation; no positive reaction was observed. B) Enlarged image
of the box in panel A. C) Epidermis at 20 days of development without cytokeratin 5/6
expression; in this picture, a developing hair follicle shows a negative reaction. D)
Epidermis at 5 post-natal days; a reaction was restricted to basal keratinocytes and secret-
ing sebum cells. E) Adult epidermis showing the positive reaction at the sebaceous
glands. F) Magnification of the box in panel E. White arrows indicate the sebaceous
gland showing positive expression. 
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basal cells while Muc1 may be reactive on
some of them.22,23 In our study, both markers
were found only in post-natally skin at seba-
ceous gland and in some cases at basal ker-
atinocytes. Our results show that cytokeratins
5/6 and Muc1 were expressed at sebum glands
and at some basal keratinocytes belonging to
neonate and adult specimens while neither
Muc1 nor cytokeratins 5/6 were detected on
embryonic epidermis. These interesting find-
ings constitute an advance on elucidating anti-
genic expression on skin rat since Muc1 and
Muc5ac are expressed early after birth and
they would be related to complete development
of sebum glands although do not indicate a
relationship between Muc5ac embryonic posi-
tive cells and those giving rise to adult sebum
cells.
The results here obtained by IHC were con-
firmed by SDS-PAGE/WB analysis; in all posi-
tive cases, a band at approximately 200 kDa
was detected. In most reports SDS-PAGE/WB
have been employed to obtain, identify and
determine mucin molecular weights, including
human MUC5AC,24 and Muc5ac in rats.25 In a
previous report,11 as well as the results pre-
sented here, we found that the
MUC5AC/Muc5ac MW is about 200 kDa, which
are in coincidence with the results obtained by
Reis et al.24 They have intensively studied
MUC5AC and, employing SDS-PAGE found that
the MW of MUC5AC was >200 kDa.
Furthermore, Mata et al.25 studied a rat model
and employed 8% SDS-PAGE; they detected
Muc5ac at a MW of 213 kDa using MAb 45M1
(the same as we employed). Also in rat sys-
tems, lung homogenates, Xiao et al.26 and Ning
et al.27 employed SDS-PAGE/WB to identify
Muc5ac at 10% and 8%, respectively. Other
reports employed agarose gels to identify
MUC5AC,28,29 which may be also useful to
detect particular molecular intermediates.17
Neonatal skin samples showed a strong inten-
sity of reaction at early days post-birth with a
gradual decline at 10PD. Furthermore, all the
analyzed cDNA samples of embryonic, fetal,
neonatal, and adult skin showed mRNA
Muc5ac expression. It is known that mucins
are produced by all epithelial cells, although
the combination and relative amount of indi-
vidual mucins vary by cell and tissue type. In a
system also derived from the surface epitheli-
um, which include adult epithelia of cornea
and conjunctiva, it has been described the pro-
duction of MUC5AC, MUC1, MUC4 and
MUC16. MUC5AC is synthesized by conjuncti-
val goblet cells while MUC1 is produced by
corneal and conjunctival epithelia, MUC4
mainly by the conjunctiva, and MUC16 is found
at apical corneal epithelial cells and at the
lacrimal gland ductal epithelium, accessory
lacrimal glands, and nasolacrimal duct epithe-
lium.30 In another system, the mucins produced
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Figure 4. Expression of Muc1 determinates using immunohistochemistry in rat skin sam-
ples of embryos and adults. A) Epidermis at 20 days of gestation showing a negative reac-
tion. B) Adult skin; the reaction was restricted to the sebaceous glands. C) Magnification of
the box in panel B. D) Sebaceous glands of adult skin showing a high Muc1 expression. 
Figure 5. Western blot analysis employing anti-MUC5AC MAb, 45M1. Homogenates
from epidermis belonging to fetuses at 20, 19, 18 and 17 days of gestation (A) and to
neonates between 3-10 days post birth (B). All samples show a strong reaction band at
about 200 kDa, a lower intensity at 10 days post birth is observed. Ctl+, positive control.
Figure 6. Muc5ac mRNA analysis using RT-PCR of skin rat embryos at D16, D19 and
D20 days of gestation (A) and neonates at 7 days post birth and adults (B); a band about
149 bp is detected in all samples; RNA was used as normalizer. MW, standard of molec-
ular weight pGEM1 (Promega, Madison, WI, USA).
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in the adult human airway epithelium are
MUC5AC and MUC5B, 90% and MUC1, MUC4
and MUC16, 10%. MUC5AC is produced by gob-
let cells while ciliated cells synthesize MUC1,
MUC4 and MUC16, and mucus gland cells pro-
duce MUC5B and MUC16.31-33
The fact that Muc5ac is expressed in rat
embryonic epidermis and in post-natal and
adult sebum cells of hair associated glands, let
us to hypothesize that Muc5ac may play a pro-
tective role in embryonic skin previous to birth
which may be replaced by pile covering. As
MUC5AC has been implicated in human skin
conditions, animal models would be important
to clarify biological and medical aspects. To our
knowledge, this is the first report that shows
Muc5ac expression during skin development.
References
1. Watt FM. The stem cell compartment in
human interfollicular epidermis. J
Dermatol Sci 2002;28:173-80.
2. Rose MC, Voynow JA. Respiratory tract
mucin genes and mucin glycoproteins in
health and disease. Physiol Rev
2006;86:245-78.
3. Buisine MP, Desseyn JL, Porchet N,
Degand P, Laine A, Aubert JP. Genomic
organization of the 3'-region of the human
muc5ac mucin gene: additional evidence
for a common ancestral gene for the
11p15.5 mucin gene family. Biochem J
1998;332:729-38.
4. Chakraborty S, Bonthu N, Swanson BJ,
Batra SK. Role of mucins in the skin
during benign and malignant conditions.
Cancer Lett 2011;301:127-41.
5. Smith RF, Stern BH, Smith AA. Mucin
immunohistochemistry in the diagnosis
and mapping of extramammary paget's
disease. J Cell Mol Med 2008;12:1605-10.
6. Buisine MP, Devisme L, Copin M, Durand-
Reville M, Gosselin B, Aubert JP
Developmental mucin gene expression in
the human respiratory tract. Am J Res Cell
Mol Biol 1999;20:209-18.
7. Lacunza E, Ferretti VA, Barbeito C, Segal-
Eiras A, Croce MV. Immunohistochemical
evidence of Muc1 expression during rat
embryonic development. Eur J Histochem
2010;54:e49.
8. Bara J, Gautier R, Mouradian P, Decaens
C, Daher N. Oncofetal mucin m1 epitope
family: characterization and expression
during colonic carcinogenesis. Int J
Cancer 1991;47:304-10.
9. Lidell ME, Bara J, Hansson GC. Mapping of
the 45m1 epitope to the c-terminal cystei-
ne-rich part of the human MUC5AC
mucin. FEBS J 2008;275:481-9.
10. Croce MV, Isla-Larrain MT, Rua CE,
Rabassa ME, Gendler SJ, Segal-Eiras A.
Patterns of Muc1 tissue expression defi-
ned by an anti-MUC1 cytoplasmic tail
monoclonal antibody in breast cancer. J
Histochem Cytochem 2003;51:781-8.
11. Lacunza E, Bara J, Segal-Eiras A Croce MV.
Expression of conserved mucin domains
by epithelial tissues in various mamma-
lian species. Res Vet Sci 2009;8:68-77.
12. Li R, Meng Z, Xie J. Effects of sulfur dioxi-
de on the expressions of MUC5AC and
ICAM-1 in airway of asthmatic rats. Regul
Toxicol Pharmacol 2007;48:284-91. 
13. Schmittgen TD, Zakrajsek BA. Effect of
experimental treatment on housekeeping
gene expression: validation by real-time,
quantitative RT-PCR. J Biochem Biophys
Methods 2000;46:69-81.
14. Inatomi T, Tisdale AS, Zhan Q, Spurr-
Michaud S, Gipson IK. Cloning of rat
muc5ac mucin gene: comparison of its
structure and tissue distribution to that of
human and mouse homologues. Biochem
Biophys Res Comm 1997;236:789-97.
15. Yoshii N, Kitajima S, Yonezawa S,
Matsukita S, Setoyama M, Kanzaki T.
Expression of mucin core proteins in
extramammary Paget's disease. Pathol Int
2002;52:390-9.
16. Biemer-Hüttmann A, Walsh MD, McGuckin
MA, Ajioka Y, Watanabe H, Leggett BA, et
al. Immunohistochemical staining pat-
terns of MUC1, MUC2, MUC4, and
MUC5AC mucins in hyperplastic polyps,
serrated adenomas, and traditional adeno-
mas of the colorectum. J Histochem
Cytochem 1999;47:1039-44.  
17. Sheehan JK, Kirkham S, Howard M,
Woodman P, Kutay S, Brazeau C, et al.
Identification of Molecular Intermediates
in the Assembly Pathway of the MUC5AC
Mucin. J Biol Chem 2004;279:15698-705.
18. Fluhr JW, Mao-Qiang M, Brown BE,
Hachem JP, Moskowitz DG, Demerjian M,
et al. Functional consequences of a neutral
pH in neonatal rat stratum corneum. J
Invest Dermatol 2004;123:140-51.
19. Zhang Yasin M, Carraway CA, Carraway
KL. MUC4-4 expression and localization in
gastrointestinal tract and skin of human
embryos. Tissue Cell 2006;38:271-5.
20. Thornton DJ, Sheehan JK. From mucins to
mucus: toward a more coherent unders-
tanding of this essential barrier. Proc Am
Thorac Soc 2004;1:54-61.
21. Ehre C, Worthington EN, Liesman RM,
Grubb BR, Barbier D, O'Neal WK, et al.
Overexpressing mouse model demonstra-
tes the protective role of Muc5ac in the
lungs. Proc Natl Acad Sci USA. 2012; 109:
16528-33.
22. Chu PG, Weiss LM. Keratin expression in
human tissues and neoplasms.
Histopathology 2002; 40:403-39.
23. Fuertes L, Santonja C, Kutzner H, Requena
L. Immunohistochemistry in dermatopa-
thology: a review of the most commonly
used antibodies (part I). Actas
Dermosifiliogr 2013;104:99-127. 
24. Reis C, David L, Nielsen P, Clausen H,
Mirgorodskaya K, Roepstorff P, et al.
Immunohistochemical study of MUC5AC
expression in human gastric carcinomas
using a novel monoclonal antibody. Int J
Cancer 1997; 74:112-21. 
25. Mata M, Ruíz A, Cerdá M, Martinez-Losa
M, Cortijo J, Santangelo F, et al. Oral N-
acetylcysteine reduces bleomycin-induced
lung damage and mucin Muc5ac expres-
sion in rats. Eur Respir J 2003;22:900-5. 
26. Xiao J, Wang K, Feng Y, Chen X,  Xu D,
Zhang M. Role of extracellular signal regu-
lated kinase 1/2 in cigarette smoke-indu-
ced mucus hypersecretion in a rat model.
Chin Med J 2011;124:3327-33.
27. Ning Y, Shang Y, Huang H, Zhang J, Dong
Y, Xu W, et al. Attenuation of cigarette
smoke-induced airway mucus production
by hydrogen-rich saline in rats. PLOSOne
2013;8:e83429.
28. Vincent A, Perrais M, Desseyn J-L, Aubert
J-P,  Pigny P, Van Seuningen I. Epigenetic
regulation (DNA methylation, histone
modifications) of the 11p15 mucin genes
(MUC2, MUC5AC, MUC5B, MUC6) in epi-
thelial cancer cells. Oncogene 2007;26:
6566-76.
29. Spurr-Michaud S, Argüeso P, Gipson I.
Assay of mucins in human tear fluid. Exp
Eye Res 2007;84:939-50. 
30. Gipson IK. The ocular surface: the challen-
ge to enable and protect vision: the
Friedenwald lecture. Invest Ophthalmol
Vis Sci 2007;48:4391-8. 
31. Sheehan JK, Kesimer M, Pickles R. Innate
immunity and mucus structure and func-
tion. Novartis Found Symp 2006;279:155-
66 discussion 167-9, 216-9. 
32. Hatrupp Ch, Gendler SJ. Structure and func-
tion of the cell surface (tethered) mucins.
Annual Rev Physiol 2008;70:431-57. 
33. Thornton DJ, Rosseau K, McGuckin M.
Structure and function of the polymeric
mucins in airways mucus. Annual Rev
Physiol 2008;70:459-86.
                                                                                                           Brief Report
EJH_2015_01_BR.qxp_Hrev_master  19/02/15  14:37  Pagina 27
No
 co
m
erc
i l
 us
e o
nly
